CRISPR THERAPEUTICS AG
P/E (Price-to-Earnings)
Price
EPS
P/E (Price-to-Earnings)
| Fiscal Year | P/E (Price-to-Earnings) | EPS | Price |
|---|---|---|---|
| Jun 2020 | 332.85x | $0.46 | $153.11 |
| Dec 2021 | 16.12x | $4.70 | $75.78 |
| Mar 2022 | 10.45x | $3.89 | $40.65 |
P/E (Price-to-Earnings)
Price
EPS
P/E (Price-to-Earnings)
| Fiscal Year | P/E (Price-to-Earnings) | EPS | Price |
|---|---|---|---|
| Jun 2020 | 332.85x | $0.46 | $153.11 |
| Dec 2021 | 16.12x | $4.70 | $75.78 |
| Mar 2022 | 10.45x | $3.89 | $40.65 |